Corvus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2026 | 7.17 M | $107.05 M | 0.00% | 7.96% |
| BLACKROCK, INC. | 08/07/2026 | 7.14 M | $106.65 M | 15.88% | 7.93% |
| STATE STREET CORP | 08/07/2026 | 4.47 M | $66.84 M | 25.47% | 4.97% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 3.79 M | $56.61 M | 29.88% | 4.21% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.29 M | $49.19 M | 1.80% | 3.66% |
| ADAMS STREET PARTNERS LLC | 08/14/2026 | 3.28 M | $48.94 M | 0.00% | 3.64% |
| VIVO CAPITAL, LLC | 08/14/2026 | 2.81 M | $41.92 M | 0.00% | 3.12% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 2.73 M | $40.81 M | 17.82% | 3.04% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 2.67 M | $39.85 M | 16.36% | 2.96% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 2.49 M | $37.23 M | 0.02% | 2.77% |
| BRAIDWELL LP | 08/14/2026 | 2.13 M | $31.77 M | 21.31% | 2.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.85 M | $27.70 M | 8.23% | 2.06% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/14/2026 | 1.83 M | $27.36 M | 0.00% | 2.03% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.58 M | $23.55 M | 2.31% | 1.75% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.57 M | $23.48 M | 17.73% | 1.75% |
| MORGAN STANLEY | 08/13/2026 | 1.34 M | $20.09 M | -46.19% | 1.49% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.10 M | $16.43 M | 0.00% | 1.22% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.08 M | $16.15 M | 21.18% | 1.20% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 08/24/2026 | 1.06 M | $70.92 M | 30,190.02% | 1.18% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.05 M | $15.66 M | 20.96% | 1.16% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 814.75 K | $12.17 M | 21.62% | 0.91% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 785.21 K | $11.73 M | 45.44% | 0.87% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 757.80 K | $11.32 M | 219.74% | 0.84% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 750.00 K | $11.21 M | 0.00% | 0.83% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 747.99 K | $11.18 M | 100.00% | 0.83% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 685.68 K | $10.24 M | -0.08% | 0.76% |
| DCF ADVISERS, LLC | 08/10/2026 | 637.50 K | $9.52 M | 0.00% | 0.71% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 608.60 K | $9.09 M | 11.67% | 0.68% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 585.00 K | $8.74 M | 7.66% | 0.65% |
| NORTHERN TRUST CORP | 08/13/2026 | 575.16 K | $8.59 M | 13.64% | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/05/2026 | 526.39 K | $7.86 M | 14.62% | 0.58% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 520.53 K | $7.78 M | 3.15% | 0.58% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 450.00 K | $6.72 M | 0.00% | 0.50% |
| NEXTECH INVEST, LTD. | 08/14/2026 | 450.00 K | $6.72 M | 0.00% | 0.50% |
| CITADEL ADVISORS LLC | 08/14/2026 | 446.80 K | $6.68 M | 66.84% | 0.50% |
| CITADEL ADVISORS LLC | 08/14/2026 | 397.95 K | $5.95 M | -10.07% | 0.44% |
| UBS GROUP AG | 08/13/2026 | 396.12 K | $5.92 M | 37.01% | 0.44% |
| BARCLAYS PLC | 08/14/2026 | 315.75 K | $4.72 M | 29.52% | 0.35% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 313.40 K | $4.68 M | 111.97% | 0.35% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 296.35 K | $4.43 M | 100.00% | 0.33% |
| DIADEMA PARTNERS LP | 08/14/2026 | 294.81 K | $4.40 M | 20.42% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 274.50 K | $4.10 M | 47.26% | 0.31% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 08/13/2026 | 263.66 K | $3.94 M | 43.93% | 0.29% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 08/14/2026 | 250.29 K | $3.74 M | 49.01% | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 244.96 K | $3.66 M | -1.21% | 0.27% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 231.59 K | $3.46 M | 0.00% | 0.26% |
| SEB ASSET MANAGEMENT AB | 08/04/2026 | 226.84 K | $3.39 M | 0.00% | 0.25% |
| VICTORY CAPITAL MANAGEMENT INC | 08/07/2026 | 220.76 K | $3.30 M | 72.00% | 0.25% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 217.75 K | $3.25 M | 159.51% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 208.12 K | $3.11 M | 10.63% | 0.23% |
Corvus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 233 institutional investors and hedge funds held shares of Corvus Pharmaceuticals Inc. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.17 M
BlackRock, Inc.: 7.14 M
STATE STREET CORP: 4.47 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.79 M
VANGUARD CAPITAL MANAGEMENT LLC: 3.29 M
ADAMS STREET PARTNERS LLC: 3.28 M
78.71% of Corvus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 77.59 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.